Published
Combining NVIDIA's world-leading accelerated computing and Schrödinger's novel drug discovery platform enables rapid, accurate evaluation of billions of molecules for the potential development of therapeutics, reducing the cost of preclinical drug discovery. Learn more: https://nvda.ws/3fUH2JF
#drugresearch #drugdevelopment #machinelearning
#drugresearch #drugdevelopment #machinelearning
Sign in or sign up to post comments.
Be the first to comment
Up Next
-
04:27
Microsoft Azure Quantum and PNNL join forces to accelerate scientific discovery
-
01:46
Accelerate Production-Ready AI with NVIDIA AI Enterprise
-
04:32
Unilever and Microsoft are teaming-up to accelerate scientific discovery
-
07:43
Accelerate Innovation with NVIDIA and Dell Technologies
-
03:54
Worldwide Partner Conference: Day 1 Recap
-
01:31
Accelerate Production Ready AI with NVIDIA AI Enterprise
-
02:33
Genentech and NVIDIA Revolutionize Drug Discovery with Generative AI in Lab in the Loop
-
01:12
Generative AI for Drug Discovery and Design
-
00:40
Drug Discovery Set for Deep Learning Transformation Powered by GPUs
-
01:07
Intel and NVIDIA Accelerate Professional Workstation Performance
-
02:36
How NVIDIA GPUs Accelerate Adobe Illustrator CC
-
03:32
U.S. Building Two Flagship Supercomputers to Accelerate Scientific Discovery
-
02:06
NVIDIA and Arm Accelerate HPC Worldwide
-
01:14
GSK and NVIDIA Partner on AI-Powered Lab for Discovery of Medicines and Vaccines
-
01:19
Using AI to Accelerate Scientific Discovery
-
02:13
Accelerate AI Workloads for Healthcare with NVIDIA and VMware
-
03:29
U.S. Building 2 Flagship Supercomputers to Accelerate Scientific Discovery
-
02:20
AstraZeneca: Accelerating Drug Discovery with Machine Learning and AI on Cambridge-1
-
13:04
Satya Nadella: Worldwide Partner Conference 2016
-
02:07
Accelerate Breakthroughs with NVIDIA GPU Cloud
-
02:24
Accelerate AI-Powered Drug Discovery With NVIDIA BioNeMo
-
02:40
Future of Cellular: T-Mobile & NVIDIA Accelerate AI-RAN Commercialization
Loading...